Regarding F-PSA results, no significant changes were observed at any time, indicating that neither ev-F-PSA concentrations nor the F-PSA ev/srm ratio would be suitable alternatives as PCa monitoring biomarkers during the course of the disease. The gene discussed is KLK3; the disease is posterior cortical atrophy.